Example: Heart Attack

Clinical Trials Sponsored by Arrowhead Pharmaceuticals

Total 29 results

NCT05089084

Recruiting

Study of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome (FCS)

Conditions: Familial Chylomicronemia
NCT03946449

Active, not recruiting

Study of ARO-AAT in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)

Conditions: Alpha 1-Antitrypsin Deficiency
NCT05217667

Recruiting

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Conditions: Homozygous Familial Hypercholesterolemia
NCT04720534

Recruiting

Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

Conditions: Severe Hypertriglyceridemia
NCT04998201

Recruiting

Study of ARO-APOC3 in Adults With Mixed Dyslipidemia

Conditions: Mixed Dyslipidemia
NCT05292950

Not yet recruiting

Study of ARO-MUC5AC in Healthy Subjects and Patients With Asthma

Conditions: Asthma
NCT05276570

Not yet recruiting

Study of ARO-RAGE in Healthy Subjects and Patients With Asthma

Conditions: Asthma
NCT03945292

Active, not recruiting

Safety, Tolerability and Pharmacodynamic Effect of ARO-AAT

Conditions: Alpha 1-Antitrypsin Deficiency
NCT04375514

Terminated

Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis

Conditions: Cystic Fibrosis, Pulmonary
NCT05083364

Recruiting

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria and Complement-Mediated Renal Disease

Conditions: Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy
NCT04832971

Recruiting

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

Conditions: Mixed Dyslipidemia
NCT04202354

Completed

Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH

Conditions: Non-alcoholic Steatohepatitis
NCT03747224

Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Conditions: Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia
NCT04169711

Recruiting

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Conditions: Clear Cell Renal Cell Carcinoma
NCT03365947

Completed

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

Conditions: Hepatitis B
NCT03783377

Completed

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Conditions: Hypertriglyceridemia, Familial Chylomicronemia
NCT03362242

Completed

Study of ARO-AAT in Normal Adult Volunteers

Conditions: Alpha 1-Antitrypsin Deficiency
NCT02065336

Terminated

A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Conditions: Hepatitis B, Chronic
NCT02738008

Terminated

Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection

Conditions: Hepatitis B
NCT02604212

Terminated

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection

Conditions: Hepatitis B
NCT02604199

Terminated

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection

Conditions: Hepatitis B
NCT02577029

Terminated

Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)

Conditions: Hepatitis B, Hepatitis D
NCT02797522

Terminated

A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)

Conditions: Hepatitis B
NCT02363946

Terminated

A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Conditions: Alpha-1 Antitrypsin Deficiency
NCT02535416

Completed

A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers

Conditions: Healthy

Clinical Trials Sponsored by Arrowhead Pharmaceuticals

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations